← Back to Skills Marketplace
hanxueyuan

Amgen

by hanxueyuan · GitHub ↗ · v1.0.0 · MIT-0
cross-platform ✓ Security Clean
128
Downloads
0
Stars
0
Active Installs
1
Versions
Install in OpenClaw
/install amgen
Description
全球第三大生物技术公司，专注肿瘤学、骨科学及炎症，2024年营收约290亿美元，拥有领先重组蛋白技术和产品组合。
README (SKILL.md)

安进 · Amgen

"生物技术行业的奠基者，重组蛋白药物的开拓者"

Amgen 是全球生物技术行业的先驱和领导者之一，成立于 1980 年。公司利用重组 DNA 技术开发了多种革命性药物，在肿瘤学骨科学炎症和心血管疾病领域拥有强大的商业化产品组合。

历史时间线

时期 关键事件
1980 风险投资家 William Bowes 和科学家团队在加州创立
1983 在纳斯达克上市，生物技术行业早期上市公司
1989 Epogen 促红细胞生成素获批，首个商业化重组蛋白药物
2000 以 190 亿美元收购 Immunex，获得 Enbrel
2011 Xgeva 和 Prolia 骨科学药物获批上市
2019 以 278 亿美元收购 Otezla 的母公司
2021 Lumakras 肺癌靶向药物获批，突破 KRAS 不可成药靶点
2024 肥胖症药物 MariTide 进入三期临床，开启新增长曲线

业务结构分析

肿瘤学

肺癌血液肿瘤和乳腺癌靶向治疗药物组合

骨科学

Prolia 和 Xgeva 骨质疏松和骨转移治疗，市场领先

炎症

Enbrel 和 Otezla 自身免疫疾病治疗药物

心血管和代谢

Repatha 降胆固醇药物和 MariTide 肥胖症在研管线

核心护城河

  生物技术飞轮
    |
    重组DNA技术平台 --> 持续创新
    |                                |
    大规模临床开发 --> 重磅药物
    |                                |
    全球商业化网络 --> 收入增长
    |                                |
    并购补充管线 --> 多元化
  1. 重组蛋白药物领域的先驱，拥有超过 40 年的技术积累
  2. Enbrel 是全球销量最高的自身免疫药物之一，累计销售超过 1000 亿美元
  3. Lumakras 首次突破了 KRAS 突变这个数十年不可成药的靶点
  4. 在肥胖症领域的 MariTide 可能成为下一个重磅增长驱动

关键数据

指标 数值
年营收 约 290 亿美元（2024）
Enbrel年销 约 50 亿美元
Prolia年销 约 35 亿美元
员工数 约 25,000 人
研发投入占比 约 25%
全球市场覆盖 超过 100 个国家

值得了解

  • Amgen 这个名字来自 AMGen 即 Applied Molecular Genetics 的缩写

  • 公司总部所在的千橡市 Thousand Oaks 现在是全球生物技术产业的中心之一

  • Epogen 是第一个利用重组 DNA 技术大规模生产的蛋白质药物

  • Lumakras 的发现过程被 Science 杂志评为 2021 年十大科学突破之一

Usage Guidance
This skill is essentially a static Amgen company profile and is internally coherent. Before relying on it for decisions: verify facts (dates, revenues, drug approvals) against primary sources (Amgen filings, press releases, regulators), be aware the SKILL.md may be outdated or contain inaccuracies, and do not expect it to perform network or system actions—there are no credentials or install steps. If you need live data (stock prices, filings), prefer a skill that declares the specific API and credentials it uses.
Capability Analysis
Type: OpenClaw Skill Name: amgen Version: 1.0.0 The skill bundle contains purely informational content about the biotechnology company Amgen. It consists of a metadata file and a Markdown document (SKILL.md) providing historical data, business analysis, and financial metrics. There is no executable code, no network activity, and no evidence of prompt injection or malicious intent.
Capability Assessment
✓ Purpose & Capability
Name/description (Amgen company profile) match the SKILL.md content. The skill does not declare or request unrelated binaries, credentials, or config paths.
✓ Instruction Scope
SKILL.md contains static company information and 'read_when' triggers for relevant queries (company info, competition, business model, investment analysis). It does not instruct the agent to read local files, access other environment variables, or transmit data to external endpoints.
✓ Install Mechanism
No install spec and no code files are present (instruction-only), so nothing is written to disk or downloaded during install.
✓ Credentials
The skill requires no environment variables, credentials, or config paths. No disproportionate secret access is requested.
✓ Persistence & Privilege
always is false and there is no indication the skill modifies agent/system settings or requests long-term presence. Autonomous invocation is allowed (platform default) but presents minimal risk given the skill's read-only, static nature.
How to Use
  1. Make sure OpenClaw is installed (local or Docker)
  2. Run the install command in chat: /install amgen
  3. After installation, invoke the skill by name or use /amgen
  4. Provide required inputs per the skill's parameter spec and get structured output
Version History
v1.0.0
- 添加了Amgen公司（安进）的详细中文资料库，概述其为全球第三大生物技术公司，2024年营收约290亿美元。 - 补充公司历史重要里程碑、产品线分布、业务结构及核心竞争力描述。 - 提供了覆盖肿瘤、骨科、炎症、心血管/代谢四大领域的主要药物及研发管线信息。 - 展示关键经营/财务数据，方便投资、行业对比及公司研究使用。 - 增列关于公司名称、地理与技术创新相关的知识点。
Metadata
Slug amgen
Version 1.0.0
License MIT-0
All-time Installs 0
Active Installs 0
Total Versions 1
Frequently Asked Questions

What is Amgen?

全球第三大生物技术公司，专注肿瘤学、骨科学及炎症，2024年营收约290亿美元，拥有领先重组蛋白技术和产品组合。 It is an AI Agent Skill for Claude Code / OpenClaw, with 128 downloads so far.

How do I install Amgen?

Run "/install amgen" in the OpenClaw or Claude Code chat to install it in one step — no extra setup required.

Is Amgen free?

Yes, Amgen is completely free, licensed under MIT-0. You can download, install and use it at no cost.

Which platforms does Amgen support?

Amgen is cross-platform and runs anywhere OpenClaw / Claude Code is available (cross-platform).

Who created Amgen?

It is built and maintained by hanxueyuan (@hanxueyuan); the current version is v1.0.0.

More Skills
self-improving agent
Captures learnings, errors, and corrections to enable continuous improvement. Use when: (1) A command or operation fails unexpectedly, (2) User corrects Clau...
⬇ 463283 · by pskoett
Skill Vetter
Security-first skill vetting for AI agents. Use before installing any skill from ClawdHub, GitHub, or other sources. Checks for red flags, permission scope, and suspicious patterns.
⬇ 259410 · by spclaudehome
Polymarket
Query Polymarket prediction markets. Check odds, find trending markets, search events, track price movements.
⬇ 232503 · by joelchance
Self-Improving + Proactive Agent
Self-reflection + Self-criticism + Self-learning + Self-organizing memory. Agent evaluates its own work, catches mistakes, and improves permanently. Use when...
⬇ 200423 · by ivangdavila
Github
Interact with GitHub using the `gh` CLI. Use `gh issue`, `gh pr`, `gh run`, and `gh api` for issues, PRs, CI runs, and advanced queries.
⬇ 191115 · by steipete
ontology
Typed knowledge graph for structured agent memory and composable skills. Use when creating/querying entities (Person, Project, Task, Event, Document), linkin...
⬇ 190156 · by oswalpalash

💬 Comments